AZ-11665362 is a CRTh2 ( DP2 ) receptor antagonist with an IC 50 of 2.6 nM. AZ-11665362 shows weak activity against aldose reductase , serotonin transporter , CYP 2C19 , and CYP 2C9 . AZ-11665362 lacks measurable inhibitory activity against COX-1 and COX-2 . AZ-11665362 can be used for the research of asthma, and other inflammatory diseases.
Products | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Lower Respiratory Inflammation | Products > Disease Areas > Respiratory Inflammation | Products > Disease Areas > Asthma | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Prostaglandin Receptor | Products > Signaling Pathways > Serotonin Transporter | Products > Signaling Pathways > Aldose Reductase | Products > Signaling Pathways > Cytochrome P450
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.